Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fel d 1 is the principal allergenic protein complex produced by domestic cats (Felis catus), classified as a glycosylated secretoglobin of approximately 35–39 kDa that forms a tetrameric structure composed of two heterodimers, each consisting of chain 1 (8 kDa, ~70 amino acids) and chain 2 (10 kDa, ~90–92 amino acids), covalently linked via disulfide bonds[1][3][5][7]. Synthesized mainly in sebaceous and salivary glands, Fel d 1 is distributed throughout cat fur and dander during grooming, subsequently becoming airborne and adhering strongly to environmental surfaces, contributing to its status as the primary cause of cat allergy in humans[1][4][8]. It elicits IgE-mediated hypersensitivity (allergic rhinitis, asthma) in sensitized individuals, accounting for the majority of human cat allergies[1][3][8]. The precise biological function of Fel d 1 in felines remains unknown, though it shares structural similarity with uteroglobins and may be involved in ligand binding or immune modulation[2][3][7]. Targeting Fel d 1 by reduction of environmental levels, neutralization with specific antibodies, or immune desensitization forms the basis for investigational and experimental allergy therapies[3][8].
Neutralizing antibodies sequester Fel d 1 to prevent IgE binding; Immunotherapy induces blocking IgG or alters T cell responses against Fel d 1
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fel d 1 allergen protein complex (Fel d 1).